Viewing Study NCT05499260


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-23 @ 9:22 PM
Study NCT ID: NCT05499260
Status: UNKNOWN
Last Update Posted: 2022-08-16
First Post: 2022-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
Sponsor: Shanghai Zhimeng Biopharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module